Efficacy of hyperbaric oxygen therapy in treating fibromyalgia linked to childhood trauma after late-onset and over a decade of symptoms: a case report.
{"title":"Efficacy of hyperbaric oxygen therapy in treating fibromyalgia linked to childhood trauma after late-onset and over a decade of symptoms: a case report.","authors":"Mouzayan Ginzarly, Sherif Khairy, Zemer Wang, Umair Qureshi, Raghda Zaitoun, Shai Efrati","doi":"10.1186/s13256-025-05453-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fibromyalgia syndrome is a chronic pain disorder characterized by central sensitization and neuroinflammation. Conventional treatments primarily focus on symptom management but often fail to address the underlying dysfunction. Hyperbaric oxygen therapy has emerged as a promising approach that promotes neuroplasticity and may provide symptom relief.</p><p><strong>Case presentation: </strong>We present the case of a 62-year-old North African female patient with treatment-resistant fibromyalgia and a history of childhood trauma who underwent 60 hyperbaric oxygen therapy sessions over 12 weeks (90 min at 2.0 atmospheres absolute). Baseline and posttreatment assessments included clinical evaluations (Fibromyalgia Impact Questionnaire Revised, widespread pain index, and symptom severity scale), neurocognitive testing, magnetic resonance imaging-diffusion tensor imaging, single-photon emission computed tomography imaging, and functional mobility tests. Following hyperbaric oxygen therapy, the patient reported substantial pain reduction (Fibromyalgia Impact Questionnaire Revised score decreased from 60.5 to 44; Fibromyalgia Diagnostic Criteria Questionnaire score decreased from 16 to 12). Computerized cognitive assessments revealed a 10% improvement in global cognitive function and a 26.9% increase in attention. Medication use was also reduced, with the discontinuation of pregabalin (Lyrica) and a 50% reduction in duloxetine (Cymbalta) dosage. Additionally, physical function improved, with walking speed increasing from 3.2 to 4.5 km/h and notable gains in balance and coordination. Corresponding to the clinical improvements, the brain imaging demonstrated increased perfusion on single-photon emission computed tomography and enhanced white matter integrity on magnetic resonance imaging-diffusion tensor imaging.</p><p><strong>Conclusion: </strong>Hyperbaric oxygen therapy promotes neuroplasticity, resulting in significant clinical improvements in fibromyalgia syndrome, including pain reduction, enhanced cognitive function, and improved physical mobility. These findings highlight the potential of hyperbaric oxygen therapy as a therapeutic strategy targeting the core pathophysiology of fibromyalgia syndrome rather than solely managing symptoms.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"19 1","pages":"386"},"PeriodicalIF":0.8000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323029/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13256-025-05453-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Fibromyalgia syndrome is a chronic pain disorder characterized by central sensitization and neuroinflammation. Conventional treatments primarily focus on symptom management but often fail to address the underlying dysfunction. Hyperbaric oxygen therapy has emerged as a promising approach that promotes neuroplasticity and may provide symptom relief.
Case presentation: We present the case of a 62-year-old North African female patient with treatment-resistant fibromyalgia and a history of childhood trauma who underwent 60 hyperbaric oxygen therapy sessions over 12 weeks (90 min at 2.0 atmospheres absolute). Baseline and posttreatment assessments included clinical evaluations (Fibromyalgia Impact Questionnaire Revised, widespread pain index, and symptom severity scale), neurocognitive testing, magnetic resonance imaging-diffusion tensor imaging, single-photon emission computed tomography imaging, and functional mobility tests. Following hyperbaric oxygen therapy, the patient reported substantial pain reduction (Fibromyalgia Impact Questionnaire Revised score decreased from 60.5 to 44; Fibromyalgia Diagnostic Criteria Questionnaire score decreased from 16 to 12). Computerized cognitive assessments revealed a 10% improvement in global cognitive function and a 26.9% increase in attention. Medication use was also reduced, with the discontinuation of pregabalin (Lyrica) and a 50% reduction in duloxetine (Cymbalta) dosage. Additionally, physical function improved, with walking speed increasing from 3.2 to 4.5 km/h and notable gains in balance and coordination. Corresponding to the clinical improvements, the brain imaging demonstrated increased perfusion on single-photon emission computed tomography and enhanced white matter integrity on magnetic resonance imaging-diffusion tensor imaging.
Conclusion: Hyperbaric oxygen therapy promotes neuroplasticity, resulting in significant clinical improvements in fibromyalgia syndrome, including pain reduction, enhanced cognitive function, and improved physical mobility. These findings highlight the potential of hyperbaric oxygen therapy as a therapeutic strategy targeting the core pathophysiology of fibromyalgia syndrome rather than solely managing symptoms.
期刊介绍:
JMCR is an open access, peer-reviewed online journal that will consider any original case report that expands the field of general medical knowledge. Reports should show one of the following: 1. Unreported or unusual side effects or adverse interactions involving medications 2. Unexpected or unusual presentations of a disease 3. New associations or variations in disease processes 4. Presentations, diagnoses and/or management of new and emerging diseases 5. An unexpected association between diseases or symptoms 6. An unexpected event in the course of observing or treating a patient 7. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect